36C26120Q0010-001.docx

Posted

Attached to
Q301--662-20-1-146-0003 Anatomic Pathology Decipher Tests: Decipher Prostate Cancer Classifier Biopsy & Decipher Prostate Cancer Classifier Post-Op Test
Solicitation number
36C26120Q0010
Issued by

About this file

From the source

36C26120Q0010 36C26120Q0010.docx

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Contract Opportunity Presolicitation Notice

CLASSIFICATION CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

RESPONSE DATE (MM-DD-YYYY)

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

SET-ASIDE

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

GENERAL INFORMATION

PLACE OF PERFORMANCE

* = Required Field Contract Opportunity Presolicitation Notice Q301 662-20-1-146-0003 Anatomic Pathology Decipher Tests: Decipher Prostate Cancer Classifier Biopsy & Decipher Prostate Cancer Classifier Post-Op Test 96819-1522 36C26120Q0010 N 621511 Department of Veterans Affairs VA Sierra Pacific Network (VISN 21) VA Pacific Islands Health Care System 459 Patterson Rd Honolulu HI 96819-1522 Licia Haynie Licia.Haynie@va.gov San Francisco VA Medical Center 4150 Clement St San Francisco, CA 92108

USA

Licia.Haynie@va.gov Licia.Haynie@va.gov

PRE-SOLICITATION NOTICE OF INTENT TO SOLE SOURCE

Department of Veterans Affairs (VA) Network Contracting Office (NCO 21) intends to award a sole source, firm fixed price contract to Decipher Corp. The contractor will provide the Decipher Prostate Cancer Test and its results. The Decipher test is a proprietary genomic test that predicts the probability of metastasis after surgery and provides independent assessment of tumor aggressiveness. San Francisco VA Medical Center physicians/providers shall rely on information taken from the subject genomic testing results to make critical clinical decisions for Veteran patient diagnoses. This proprietary testing predicts the likelihood of clinically useful endpoints like high grade disease, 5-year metastasis and 10-year prostate cancer specific mortality in VA patients diagnosed with prostate cancer.

A Justification and Approval (J&A) will be posted to https://fbohome.sam.gov/ as required by Federal Acquisition Regulation (FAR) 13.501(a)(1)(iii).

Period of Performance: April 1, 2020 through March 31, 2023

File details come from the government source that posted it. Updated .